A new look at Crohn's disease: breakdown of the mucosal antibacterial defense
- PMID: 17057212
- DOI: 10.1196/annals.1326.030
A new look at Crohn's disease: breakdown of the mucosal antibacterial defense
Abstract
Crohn's disease (CD), a chronic inflammatory disease of the intestinal mucosa is usually located in the small intestine (ileum) and or in the colon. Ileal CD has been linked to a mutation in the NOD2 gene, a bacterial recognition protein. A disturbed antimicrobial defense as provided by an arsenal of different epithelial defensins seems to be a critical factor in disease pathogenesis. Defensins are antimicrobial peptides and in the ileum are mainly expressed in Paneth cells (PCs), epithelial cells that also express NOD2. In the colon, defensins are expressed by enterocytes or metaplastic PCs. Ileal CD patients are characterized by a reduced antibacterial activity and a specific reduction of ileal PC defensins. In ileal Crohn's patients displaying a NOD2 mutation, this decrease is even more pronounced. In contrast, CD of the colon is characterized by an impaired induction of beta defensins in enterocytes. In conclusion, the regional localizations of CD, either ileal or colonic disease, can be linked to different defects in defensin expression. In line with these new findings, we predict that future therapeutic strategies aimed at restoring the host-microbe balance at the intestinal mucosa may prove superior to those that broadly suppress inflammation and adaptive immunity.
Similar articles
-
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.J Leukoc Biol. 2005 Apr;77(4):460-5. doi: 10.1189/jlb.0904543. Epub 2004 Dec 23. J Leukoc Biol. 2005. PMID: 15618294 Review.
-
Defensin-immunology in inflammatory bowel disease.Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S137-44. doi: 10.1016/S0399-8320(09)73149-5. Gastroenterol Clin Biol. 2009. PMID: 20117337
-
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.Gut. 2008 Jul;57(7):903-10. doi: 10.1136/gut.2007.142588. Epub 2008 Feb 27. Gut. 2008. PMID: 18305068
-
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.Gut. 2004 Nov;53(11):1658-64. doi: 10.1136/gut.2003.032805. Gut. 2004. PMID: 15479689 Free PMC article.
-
NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.J Endotoxin Res. 2007;13(3):135-9. doi: 10.1177/0968051907080429. J Endotoxin Res. 2007. PMID: 17621555 Review.
Cited by
-
β-defensin 118 attenuates inflammation and injury of intestinal epithelial cells upon enterotoxigenic Escherichia coli challenge.BMC Vet Res. 2022 Apr 19;18(1):142. doi: 10.1186/s12917-022-03242-3. BMC Vet Res. 2022. PMID: 35440001 Free PMC article.
-
Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.Int J Mol Sci. 2022 Feb 24;23(5):2499. doi: 10.3390/ijms23052499. Int J Mol Sci. 2022. PMID: 35269641 Free PMC article. Review.
-
Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug.Sci Rep. 2021 Jan 12;11(1):571. doi: 10.1038/s41598-020-80482-z. Sci Rep. 2021. PMID: 33436961 Free PMC article.
-
The Innate Immune System: A Trigger for Many Chronic Inflammatory Intestinal Diseases.Inflamm Intest Dis. 2016 Jul;1(2):70-77. doi: 10.1159/000445261. Epub 2016 Apr 28. Inflamm Intest Dis. 2016. PMID: 29922660 Free PMC article. Review.
-
The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.Sci Rep. 2017 Jul 11;7(1):5107. doi: 10.1038/s41598-017-05255-7. Sci Rep. 2017. PMID: 28698550 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
